Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Identify the mistake, adjust your plan, and implement corrective habits. This concise guide gives actionable steps to recover quickly and stay on track.
18,261 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
XRP recently pulled back sharply, turning the focus from hype to fundamentals. In this guide, we explore what drives ...
As markets push higher, investors wonder if a downturn is inevitable. This guide dives into history, current signals,...
A surprise drop in June inflation is pushing investors to question a July rate hike. Analysts say the july rate hike ...
Turn midweek into a strategic advantage. This guide shares 10 Wednesday reads tailored for investors, with clear take...
Among a long list of there ultra-high-yield dividend stocks, two stand out for safety and consistent income. Learn wh...
ASML dominated the latest quarter with strong results and higher guidance. This article breaks down what that could m...
Moving or changing addresses can trigger debit card fraud if the card is mailed to an old address. Learn the risks, t...
A renewed confrontation in the Persian Gulf has investors eyeing oil names. This guide breaks down what the latest bl...
Institutional landlords are stepping up the sale of single-family rentals as the ROAD Act takes effect. Early data sh...
When a company’s founder or CEO sells a chunk of stock, it sparks questions. This article breaks down the Zoom inside...
Figma reports Q4 2025 revenue of $303.8 million, up 40% year over year, pushing annual revenue over the $1 billion ma...